Wednesday, March 3, 2010
Georgiou is developing new proteins for treating liver cancer. Roy is engineering systems for delivering vaccines for lymphoma.
And they have received funding from the Cancer Prevention and Research Institute of Texas (CPRIT) that will support critical links in getting their research from their laboratories to patients.
They talked about the crucial nature of the funding last week when CPRIT officials presented a
Read More …